4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-044309
Chief Financial Officer sold 3,500 shares at $12.80 ($44,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-08-01 | Sale | −3,500 | $12.80 | $44,800 | 94,994 | D |
| Open-market sales · 3,500 sh · avg $12.80 · $44,800 | |||||||
Loading xslF345X03/doc4.xml…